Association of XRCC1 and XRCC3 gene haplotypes with the development of radiation‑induced fibrosis in patients with nasopharyngeal carcinoma

Cheuk,Isabella Wai Yin; Yip,Shea Ping; Kwong,Dora Lai Wan; Wu,Vincent Wing Cheung

doi:10.3892/mco.2014.276

Association of XRCC1 and XRCC3 gene haplotypes with the development of radiation‑induced fibrosis in patients with nasopharyngeal carcinoma

Authors:
- Isabella Wai Yin Cheuk
- Shea Ping Yip
- Dora Lai Wan Kwong
- Vincent Wing Cheung Wu
View Affiliations

Affiliations: Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong, SAR, P.R. China, Department of Clinical Oncology, Queen Mary Hospital, The University of Hong Kong, Pok Fu Lam, Hong Kong, SAR, P.R. China
Published online on: April 14, 2014 https://doi.org/10.3892/mco.2014.276
Pages: 553-558

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Radiation‑induced fibrosis is one of the late complications of radiotherapy (RT) for nasopharyngeal carcinoma (NPC). The aim of this study was to investigate the association between X-ray repair cross-complementing protein 1 and 3 (XRCC1 and XRCC3, respectively) gene haplotypes and radiation‑induced fibrosis in NPC patients. Genomic DNA was extracted from blood samples of 120 NPC patients previously treated with RT. In total, 12 tag single‑nucleotide polymorphisms (SNPs) were selected from the XRCC1 and XRCC3 genes and were genotyped using restriction fragment length polymorphism analysis or unlabeled probe melting analysis. Single‑marker and haplotype analyses were performed using multivariate logistic regression analysis. The functional variant rs861539 of XRCC3 may be associated with radiation‑induced fibrosis [asymptotic P‑value (Pasym)<0.05]. No significant association was observed between radiation‑induced fibrosis and any of the tag SNPs of XRCC1 and XRCC3 in either single‑marker or haplotype analysis after 10,000 permutations [empirical P‑value (Pemp)>0.05]. Our preliminary results indicated that the rs861539 variant of XRCC3 may be associated with an increased risk of radiation‑induced fibrosis; however, a large‑scale study is required to confirm this result.

View Figures

View References

1	Wei WI and Sham JS: Nasopharyngeal carcinoma. Lancet. 365:2041–2054. 2005. View Article : Google Scholar : PubMed/NCBI
2	Kam MK, Teo PM, Chau RM, et al: Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience. Int J Radiat Oncol Biol Phys. 60:1440–1450. 2004. View Article : Google Scholar : PubMed/NCBI
3	Lee AW, Law SC, Ng SH, et al: Retrospective analysis of nasopharyngeal carcinoma treated during 1976–1985 late complications following megavoltage irradiation. Br J Radiol. 65:918–928. 1992.
4	Alsbeih G, Al-Harbi N, Al-Hadyan K, El-Sebaie M and Al-Rajhi N: Association between normal tissue complications after radiotherapy and polymorphic variations in TGFB1 and XRCC1 genes. Radiat Res. 173:505–511. 2010. View Article : Google Scholar : PubMed/NCBI
5	Alsbeih GA, El-Sebaie MM, Al-Rajhi NM, et al: Association between XRCC1 G399A polymorphism and late complications to radiotherapy in Saudi head and neck cancer patients. J Egypt Natl Canc Inst. 20:302–308. 2008.PubMed/NCBI
6	Andreassen CN, Alsner J, Overgaard J, et al: TGFB1 polymorphisms are associated with risk of late normal tissue complications in the breast after radiotherapy for early breast cancer. Radiother Oncol. 75:18–21. 2005. View Article : Google Scholar : PubMed/NCBI
7	Andreassen CN, Alsner J, Overgaard M and Overgaard J: Prediction of normal tissue radiosensitivity from polymorphisms in candidate genes. Radiother Oncol. 69:127–135. 2003. View Article : Google Scholar : PubMed/NCBI
8	Azria D, Ozsahin M, Kramar A, et al: Single nucleotide polymorphisms, apoptosis, and the development of severe late adverse effects after radiotherapy. Clin Cancer Res. 14:6284–6288. 2008. View Article : Google Scholar : PubMed/NCBI
9	Brem R, Cox DG, Chapot B, et al: The XRCC1 -77T->C variant: haplotypes, breast cancer risk, response to radiotherapy and the cellular response to DNA damage. Carcinogenesis. 27:2469–2474. 2006.
10	Burri RJ, Stock RG, Cesaretti JA, et al: Association of single nucleotide polymorphisms in SOD2, XRCC1 and XRCC3 with susceptibility for the development of adverse effects resulting from radiotherapy for prostate cancer. Radiat Res. 170:49–59. 2008. View Article : Google Scholar : PubMed/NCBI
11	Damaraju S, Murray D, Dufour J, et al: Association of DNA repair and steroid metabolism gene polymorphisms with clinical late toxicity in patients treated with conformal radiotherapy for prostate cancer. Clin Cancer Res. 12:2545–2554. 2006. View Article : Google Scholar : PubMed/NCBI
12	Giotopoulos G, Symonds RP, Foweraker K, et al: The late radiotherapy normal tissue injury phenotypes of telangiectasia, fibrosis and atrophy in breast cancer patients have distinct genotype-dependent causes. Br J Cancer. 96:1001–1007. 2007. View Article : Google Scholar
13	Moullan N, Cox DG, Angèle S, Romestaing P, Gerard JP and Hall J: Polymorphisms in the DNA repair gene XRCC1, breast cancer risk, and response to radiotherapy. Cancer Epidemiol Biomarkers Prev. 12:1168–1174. 2003.PubMed/NCBI
14	Suga T, Iwakawa M, Tsuji H, et al: Influence of multiple genetic polymorphisms on genitourinary morbidity after carbon ion radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 72:808–813. 2008. View Article : Google Scholar : PubMed/NCBI
15	Zschenker O, Raabe A, Boeckelmann IK, et al: Association of single nucleotide polymorphisms in ATM, GSTP1, SOD2, TGFB1, XPD and XRCC1 with clinical and cellular radiosensitivity. Radiother Oncol. 97:26–32. 2010. View Article : Google Scholar : PubMed/NCBI
16	Chang-Claude J, Ambrosone CB, Lilla C, et al: Genetic polymorphisms in DNA repair and damage response genes and late normal tissue complications of radiotherapy for breast cancer. Br J Cancer. 100:1680–1686. 2009. View Article : Google Scholar : PubMed/NCBI
17	Popanda O, Marquardt JU, Chang-Claude J and Schmezer P: Genetic variation in normal tissue toxicity induced by ionizing radiation. Mutat Res. 667:58–69. 2009. View Article : Google Scholar : PubMed/NCBI
18	Alsbeih G, El-Sebaie M, Al-Harbi N, Al-Hadyan K, Shoukri M and Al-Rajhi N: SNPs in genes implicated in radiation response are associated with radiotoxicity and evoke roles as predictive and prognostic biomarkers. Radiat Oncol. 8:1252013. View Article : Google Scholar : PubMed/NCBI
19	de Bakker PI, Yelensky R, Pe’er I, Gabriel SB, Daly MJ and Altshuler D: Efficiency and power in genetic association studies. Nat Genet. 37:1217–1223. 2005.PubMed/NCBI
20	International HapMap Consortium. The International HapMap Project. Nature. 426:789–796. 2003. View Article : Google Scholar
21	Purcell S, Neale B, Todd-Brown K, et al: PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 81:pp. 559–575. 2007, http://pngu.mgh.harvard.edu/~purcell/plink. Accessed, July 19, 2013
22	Schwarzer G: Meta: An R package for meta-analysis. R News. 7:pp. 40–45. 2007, http://cran.r-project.org/web/packages/meta/index.html. Accessed, September 8, 2013
23	Higgins JPT and Green S: Cochrane Handbook for Systematic Reviews of Interventions, version 5.10. The Cochrane Collaboration; 2011, http://handbook.cochrane.org. Accessed July 27, 2013
24	Bentzen SM: Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology. Nat Rev Cancer. 6:702–713. 2006. View Article : Google Scholar : PubMed/NCBI
25	Andreassen CN and Alsner J: Genetic variants and normal tissue toxicity after radiotherapy: a systematic review. Radiother Oncol. 92:299–309. 2009. View Article : Google Scholar : PubMed/NCBI
26	Barnett GC, Coles CE, Elliott RM, et al: Independent validation of genes and polymorphisms reported to be associated with radiation toxicity: a prospective analysis study. Lancet Oncol. 13:65–77. 2012. View Article : Google Scholar : PubMed/NCBI
27	West CM, Dunning AM and Rosenstein BS: Genome-wide association studies and prediction of normal tissue toxicity. Semin Radiat Oncol. 22:91–99. 2012. View Article : Google Scholar : PubMed/NCBI
28	Talbot CJ, Tanteles GA, Barnett GC, et al: A replicated association between polymorphisms near TNFα and risk for adverse reactions to radiotherapy. Br J Cancer. 107:748–753. 2012.PubMed/NCBI
29	Kerns SL, Ostrer H, Stock R, et al: Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 78:1292–1300. 2010. View Article : Google Scholar
30	Lorimore SA, Coates PJ and Wright EG: Radiation-induced genomic instability and bystander effects: inter-related nontargeted effects of exposure to ionizing radiation. Oncogene. 22:7058–7069. 2003. View Article : Google Scholar : PubMed/NCBI
31	Barnett GC, West CM, Coles CE, et al: Standardized total average toxicity score: a scale- and grade-independent measure of late radiotherapy toxicity to facilitate pooling of data from different studies. Int J Radiat Oncol Biol Phys. 82:1065–1074. 2012. View Article : Google Scholar